Boning Liu et al. [28] demonstrated that miR-26a increases lung cancer cell migration and the risk of metastasis by modulating activation of the AKT pathway by suppressing PTEN, data which agrees with our results in MDA-MB-231 cells. The gene discussed is AKT1; the disease is lung cancer.